Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Testicular Cancer

Retroperitoneal Lymph Node Dissection

Understanding How Testicular Cancer Spreads

The lymphatic system is a network of vessels that carry lymph - a colorless fluid that contains infection-fighting white blood cells – throughout the body. As the lymph travels through the vessels it passes through small structures called lymph nodes, which act as filters. If any foreign or harmful substances are found, the immune cells in the lymph node attack and attempt to destroy them.

After a cancer diagnosis, doctors will often biopsy the lymph nodes closest to the tumor to determine if any cancer cells have broken loose and are traveling through the lymphatic system. With testicular tumors, the cancer cells will almost always spread to the lymph nodes near the aorta (the body’s main artery) and inferior vena cava (the body’s main vein) that are located in the abdominal cavity posterior to the intestines. Because the abdominal cavity is surrounded by a membrane called the peritoneum, the lymph nodes contained within it are called retroperitoneal lymph nodes.

Retroperitoneal Lymph Node Dissection (RPLND) As a Treatment Option

RPLND is surgery to remove the lymph nodes in the abdomen that are likely to contain cancer cells that have traveled (metastasized) from the primary tumor in the testicle(s). It may be the primary form of treatment for testicular cancer or a secondary form of treatment after chemotherapy. RPLND can also help to establish the exact stage and type of cancer. The procedure may be done in addition to orchiectomy (surgical removal of one or both testicles) depending on the type and stage of the tumor.

Advanced Expertise Required for Successful RPLND

Because testicular cancer is relatively rare, there are very few experts in the region trained and experienced in this proven, yet technically challenging procedure. At University Hospitals, we are pleased to offer patients the expert care of urologic oncologist, Adam Calaway, MD, who has the experience and advanced training to offer RPLND surgery as a treatment option to his patients with testicular cancer.